Aspirin 162 mg: Clinical Trials

8 trials of Aspirin 162 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 3 unknown, 2 completed. 3 Not applicable, 3 Phase 3, 2 Phase 4, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Completed 1
Phase 33Recruiting 2, Completed 1
Phase 42Recruiting 1, Unknown 1
Phase 21Completed 1

Follow Aspirin 162 mg: new trials by email Literature Review of Aspirin 162 mg trials Research Report on Aspirin 162 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Aspirin 81 mg, Aspirin 162 mg - Hypertensive Disorders of Pregnancy, Preeclampsia
Phase 4RecruitingOhio State University107422024-10-182026-10-27
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
Aspirin 162 mg, Aspirin 81mg - Pre-Eclampsia, Pregnancy Loss
Phase 3RecruitingUniversity of Pennsylvania11502024-06-122026-09-10
Trial to Determine Effective Aspirin Dose in COPD
Aspirin 81mg, Aspirin 162 mg, Aspirin 325mg - Pulmonary Disease, Chronic Obstructive
Phase 3RecruitingJohns Hopkins University482023-05-162026-03-16
162 mg of Aspirin for Prevention of Preeclampsia
Aspirin 162 mg - Preeclampsia
Phase 4UnknownMethodist Medical Center of Illinois2002021-07-062022-02-02
Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida
Aspirin 81 mg, Aspirin 162 mg - Pre-Eclampsia, Hypertension in Pregnancy
Phase 2 / Phase 3CompletedThe University of Texas Health Science Center, Houston2202019-05-062024-05-08
Aspirin for Prevention of Preeclampsia in Healthy, Nulliparous Obese and Overweight Pregnant Women
Aspirin 162 mg, Aspirin 81 mg, placebo - Preeclampsia
Not applicableUnknownAswan University Hospital6002018-12-012019-01-10
Aspirin for Prevention of Preeclampsia
aspirin 162 mg, aspirin 81 mg, placebo - Preeclampsia
Not applicableUnknownAswan University Hospital6002018-12-012019-01-10
Comparative Effects of Aspirin and NHP-544C
Bradykinin, Aspirin 81 mg, Aspirin 162 mg - Healthy
Not applicableCompletedVanderbilt University612014-07-012016-07-12

Conditions studied

Pre-Eclampsia (6)  ·  Hypertension, Pregnancy-Induced (2)  ·  Obesity (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Aswan University Hospital (2)  ·  Johns Hopkins University (1)  ·  Methodist Medical Center of Illinois (1)  ·  Ohio State University (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of Pennsylvania (1)  ·  Vanderbilt University (1)

Countries

United States (6)  ·  Egypt (2)

Top investigators

Ashraf Fawzy, MD, MPH (1)  ·  Denise Sholtens, PhD (1)  ·  Enrique Schisterman, PhD (1)  ·  Kurt Barnhart, MD (1)  ·  Maged Costantine, MD, MBA (1)  ·  Nancy J Brown, MD (1)

Results publications

PMID 27069632, PMID 27640943, PMID 28657417, PMID 28741785, PMID 29039130, PMID 29588190, PMID 29939940, PMID 31684684, PMID 32030002, PMID 32835720, PMID 3888490, PMID 724339

NIH funding

K23HL151758 (1), R01HD112308 (1)